Immunization and Vaccine-Preventable Diseases Practice Questions

Q: To achieve neonatal tetanus elimination, the incidence of neonatal tetanus per 1000 live births should be reduced to less than:

1.0. ***1.0*** - The international target for **neonatal tetanus elimination (NTE)** as defined by WHO/UNICEF is an incidence rate of **less than 1 case per 1,000 live births per year** in every district of a country. - This is the globally recognized threshold for declaring that neonatal tetanus has been eliminated as a public health problem. - Countries achieving this target at the district level are considered to have achieved NTE. *0.1* - While 0.1 per 1,000 live births represents an extremely low incidence, this is not the WHO-defined threshold for **neonatal tetanus elimination**. - The elimination target is less stringent at <1 per 1,000 live births, making disease control achievable while still representing a major public health success. *0.2* - An incidence of 0.2 per 1,000 live births, though very low, is not the internationally recognized threshold for **neonatal tetanus elimination**. - The established WHO/UNICEF target is <1 per 1,000 live births in every district. *0.5* - An incidence of 0.5 per 1,000 live births indicates excellent control of neonatal tetanus but is not the specific cut-off value. - The WHO criterion for elimination is less than 1 case per 1,000 live births per year at the district level.

Q: Minimum threshold level of herd immunity for Pertussis is?

90%. ***90%*** - Pertussis, due to its **high R-naught (R0)**, requires a very high vaccination coverage to achieve herd immunity. - An estimated 92-94% vaccination coverage is often cited as necessary to prevent outbreaks. *80%* - While 80% might be sufficient for some less contagious diseases, it's **too low a threshold** for a highly transmissible infection like pertussis. - This level would likely still allow for significant localized outbreaks, especially in unvaccinated pockets. *70%* - A 70% threshold is generally considered **insufficient** for controlling the spread of highly contagious respiratory infections. - This level of immunity would mean a higher proportion of susceptible individuals, leading to a greater risk of widespread transmission. *50%* - A 50% herd immunity level is **grossly inadequate** for a disease like pertussis, which is one of the most contagious vaccine-preventable diseases. - This low level of immunity would offer minimal protection against widespread transmission and outbreaks.

Q: Which immunization is typically given at 6 months of age?

DPT vaccine. **DPT vaccine** - The DPT (diphtheria, pertussis, and tetanus) vaccine is administered in multiple doses during infancy as part of the primary immunization series. - At **6 months of age**, the **third dose of DPT** is typically given (following doses at 6 weeks, 10 weeks, and 14 weeks according to the Indian immunization schedule). - Among the options provided, DPT is the only vaccine routinely administered at 6 months of age. - This vaccine protects against three serious bacterial infections: **diphtheria**, which can cause breathing problems; **pertussis (whooping cough)**, a severe respiratory illness; and **tetanus**, which causes painful muscle spasms. *Measles vaccine* - The measles vaccine (given as part of the **MMR vaccine** or as MR vaccine in India) is typically administered at **9 to 12 months of age** for the first dose, and a second dose between 15-18 months or 4-6 years. - It is not routinely given at 6 months, as maternal antibodies can interfere with its effectiveness at this younger age. *BCG vaccine* - The BCG (Bacillus Calmette-Guérin) vaccine protects against **tuberculosis** and is given at **birth** or in early infancy as a single dose. - It is not administered at 6 months of age. *None of the options* - This option is incorrect because the **DPT vaccine** (third dose) is a standard immunization given at 6 months of age according to the Indian immunization schedule. - Multiple vaccines are actually given at 6 months (including OPV, Hepatitis B, Hib, PCV), but among the listed options, only DPT is correct.

Q: Ideal temperature for DPT storage?

4 to 8°C. ***4 to 8°C*** - The ideal temperature for DPT (diphtheria, pertussis, tetanus) vaccine storage is between **+2°C and +8°C** (or 35°F and 46°F), which is the standard refrigerator temperature range. - This temperature range is crucial for maintaining the **potency** and **efficacy** of the vaccine, preventing **degradation** due to excessive heat or cold. *Room temperature* - Storing DPT vaccines at **room temperature** (typically 20-25°C or 68-77°F) for extended periods can lead to a **loss of potency** as heat can degrade vaccine components. - While short-term excursions within this range might be permissible under specific conditions (e.g., during transport), it is not the ideal long-term storage solution. *0 to - 20°C* - DPT vaccines, particularly the **whole-cell pertussis (wP)** component, can be **damaged by freezing**. - Temperatures below 0°C can cause the **adjuvant** (usually aluminum salt) to separate, leading to a loss of efficacy and potential local reactions at the injection site. *None of the options* - This option is incorrect because **4 to 8°C** is indeed the established and recommended ideal storage temperature for DPT vaccines.

Q: Which day is not included in the pre-exposure prophylaxis dose schedule for the rabies vaccine?

Day 3. ***Day 3*** - The standard pre-exposure prophylaxis (PrEP) schedule for rabies vaccine typically involves three doses given on **Day 0, Day 7, and Day 21 or 28**. - A dose on Day 3 is **not part of the standard recommended PrEP schedule**. *Day 0* - This is the **initial dose** in the pre-exposure prophylaxis series for rabies. - It marks the beginning of the vaccination schedule to build immunity. *Day 7* - This is the **second dose** in the pre-exposure prophylaxis series for rabies. - It follows the initial dose and is crucial for developing a robust immune response. *Day 28* - This dose, along with Day 21, can be the **final dose** in the pre-exposure prophylaxis series for rabies, depending on the specific regimen used. - It completes the primary vaccination course to ensure long-lasting protection.

Q: What is the standard amount of diphtheria toxoid in the DT vaccine?

30 Lf. ***30 Lf*** - The **DT vaccine** (pediatric diphtheria-tetanus vaccine) contains **30 Lf** of **diphtheria toxoid** per dose according to traditional formulations, along with tetanus toxoid. - This higher diphtheria toxoid content is standardized for vaccines administered to children younger than 7 years. - Note: Modern vaccine standards often express potency in **International Units (IU)** where ≥30 IU corresponds to approximately 15-25 Lf, though 30 Lf was the traditional specification. *5 Lf* - This reduced amount of diphtheria toxoid is present in adult formulations like **Tdap vaccine** and **Td vaccine** (typically 2-5 Lf). - The lower diphtheria toxoid content in adult vaccines is sufficient to maintain immunity in individuals with pre-existing immunity from childhood vaccination. *10 Lf* - This amount of diphtheria toxoid is not a standard specification for DT, Td, or Tdap vaccines. - Standard diphtheria toxoid amounts are typically 15-30 Lf for pediatric formulations (DT/DTP) and 2-5 Lf for adult formulations (Td, Tdap). *15 Lf* - While approximately 15 Lf may correspond to the minimum potency when measured in International Units (≥30 IU), the traditional standard specification for DT vaccine is **30 Lf**. - Vaccine formulations are precisely standardized to ensure optimal immunogenicity and safety.

Q: At what age can the measles vaccine be administered for the first time in high-risk scenarios or outbreak situations?

At 6 months. ***At 6 months*** - In situations of **high risk** or **outbreaks**, the measles vaccine can be given as early as **6 months of age**. - This early dose is considered an extra dose and does not count towards the routine vaccination schedule; a child would still need to receive the standard doses at 12-15 months and 4-6 years. *3 to 5 months* - The measles vaccine is generally not recommended before **6 months of age** because the presence of **maternal antibodies** can interfere with the vaccine's effectiveness. - Vaccinating at this age would likely result in an inadequate immune response. *5 to 6 months* - While closer to the recommended age for high-risk situations, the consensus for early vaccination due to high risk or outbreak remains at **6 months of age**. - Administering it slightly before 6 months may still face issues with **maternal antibody interference**, potentially reducing efficacy. *Before 3 months* - Vaccinating this early is not recommended due to significant interference from **maternal antibodies**, which are still abundant in infants. - The infant's **immune system** is also less mature, leading to an even weaker response and decreased protection.

Q: What are the serogroups covered by the bivalent meningococcal vaccine?

Serogroup A and C. ***Serogroup A and C*** - The **bivalent meningococcal vaccine** specifically targets and provides protection against **Neisseria meningitidis** serogroups **A and C**. - This vaccine is crucial for preventing invasive meningococcal disease caused by these prevalent strains, particularly in the African meningitis belt. - Examples include **meningococcal AC conjugate vaccines** used in mass vaccination campaigns. *Serogroup A* - While **Serogroup A** is one of the types covered by bivalent vaccines, it is not the only one. - A vaccine covering only Serogroup A would be a **monovalent vaccine**, not bivalent. *Serogroup W* - **Serogroup W** is covered by **quadrivalent meningococcal vaccines** (e.g., MenACWY) which protect against serogroups A, C, W, and Y. - It is **not included** in **bivalent** formulations. *Serogroup C* - While **Serogroup C** is one of the types covered by bivalent vaccines, it is not the only one. - A vaccine covering only Serogroup C would be a **monovalent vaccine**, not bivalent.

Q: What is the minimum percentage of the population that needs to be vaccinated to eradicate measles?

95%. **95%** - Measles is highly contagious, requiring a **high percentage of immunity** in the population to establish **herd immunity** and prevent outbreaks. - A **95% vaccination coverage** ensures that enough individuals are protected, breaking the chain of transmission and leading to potential eradication. *85%* - This percentage is **insufficient** for highly transmissible diseases like measles. - An 85% vaccination rate would still leave a significant portion of the population susceptible, allowing measles to **continue circulating** and causing outbreaks. *70%* - This level of vaccination is **far too low** for measles, which has a basic reproduction number (R0) of 12-18. - A 70% coverage would result in frequent and widespread measles outbreaks due to **inadequate herd immunity**. *80%* - While 80% vaccination offers some protection, it is still **below the threshold** needed for measles eradication. - Measles outbreaks can still occur with an 80% coverage, particularly in populations with **non-uniform distribution of immunity**.

Question 1

To achieve neonatal tetanus elimination, the incidence of neonatal tetanus per 1000 live births should be reduced to less than:

Accepted Answer

1.0

Answer

0.1

Answer

0.5

Answer

0.2

Question 2

Minimum threshold level of herd immunity for Pertussis is?

Accepted Answer

90%

Answer

80%

Answer

70%

Answer

50%

Question 3

Which immunization is typically given at 6 months of age?

Accepted Answer

DPT vaccine

Answer

Measles vaccine

Answer

BCG vaccine

Answer

None of the options

Question 4

Ideal temperature for DPT storage?

Accepted Answer

4 to 8°C

Answer

Room temperature

Answer

0 to - 20°C

Answer

None of the options

Question 5

Which day is not included in the pre-exposure prophylaxis dose schedule for the rabies vaccine?

Accepted Answer

Day 3

Answer

Day 0

Answer

Day 7

Answer

Day 28

Question 6

All following are at-risk group adults meriting Hepatitis B vaccination in low endemic areas except for which of the following?

Accepted Answer

Diabetics on insulin

Answer

Medical/nursing personnel

Answer

Patients with chronic liver disease

Answer

Patients on chronic hemodialysis

Question 7

What is the standard amount of diphtheria toxoid in the DT vaccine?

Accepted Answer

30 Lf

Answer

5 Lf

Answer

10 Lf

Answer

15 Lf

Question 8

At what age can the measles vaccine be administered for the first time in high-risk scenarios or outbreak situations?

Accepted Answer

At 6 months

Answer

3 to 5 months

Answer

5 to 6 months

Answer

Before 3 months

Question 9

What are the serogroups covered by the bivalent meningococcal vaccine?

Accepted Answer

Serogroup A and C

Answer

Serogroup A

Answer

Serogroup W

Answer

Serogroup C

Question 10

What is the minimum percentage of the population that needs to be vaccinated to eradicate measles?

Accepted Answer

95%

Answer

85%

Answer

70%

Answer

80%

Immunization and Vaccine-Preventable Diseases — MCQs

Immunization and Vaccine-Preventable Diseases — MCQs

On this page

Practice by Chapter

Want unlimited practice?